CLGN
Collplant Biotechnologies
$4.40
+$0.45 (+11.39%)Oct 29, 2026
Key metrics
The numbers that frame CLGN today
- Market cap
- $6.36M
- Gross margin
- -321.7%
- EV / Sales
- 20.3
- ROIC
- -239.4%
- Div yield
- 0%
- Debt / equity
- 0.9
- 52wk Low
- $2.64
- 52wk High
- $23.00
Growth
Revenue and earnings trend for CLGN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CLGN
Is Collplant Biotechnologies a good buy?
No. Collplant Biotechnologies has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Collplant Biotechnologies is selling at a very high price.
What is the market capitalization of CLGN?
Collplant Biotechnologies's market capitalization is $6.36M.
What is the 52-week high for CLGN stock?
The 52-week high for Collplant Biotechnologies is $23.00. The current close of $4.40 is 80.9% below that high.
What is the 52-week low for CLGN stock?
The 52-week low for Collplant Biotechnologies is $2.64. The current close of $4.40 is 66.7% above that low.
Does CLGN stock pay dividends?
Collplant Biotechnologies does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CLGN?
Collplant Biotechnologies's Debt / Equity ratio is 0.9.